Latest filing published 02 May 2025 for Halozyme Therapeutics, INC..
Insider track record
No signal scores available.
Akiko Moni Miyashita: trading record in brief
Akiko Moni Miyashita, listed as board member, appears in our data through filings on Halozyme Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 5 May 2022 to 1 May 2025.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 2 May 2025 came the latest disclosure, a share grant in Halozyme Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Akiko Moni Miyashita
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,165 shares0Common StockSEC:0001415889-25-011776:0
- 6,501 shares0Common StockSEC:0001415889-24-011701:0
- 8,065 shares0Common StockSEC:0001415889-23-007693:0
- 6,206 shares0Restricted Stock UnitsSEC:0001179110-22-002911:0
4 of 4 declarations
